Mike is a founding partner of Redmile Group, LLC. Prior to Redmile, Mike was a Vice President and research analyst at Steeple Capital (September 2005 through March 2007), where he covered the biotechnology, biopharmaceuticals, research tools and diagnostics industries. Prior to Steeple, he was the medical devices analyst at Welch Capital Partners and an associate on the medical devices research team at Prudential Equity Group. Mike graduated cum laude from the University of Arizona (BS, Molecular & Cellular Biology), where he studied as a Flinn Scholar. His research focus was on the role of growth factor signaling in neurology. He is on the board of Gilda’s Club New York City.